Daiwa Securities Group’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Daiwa Securities Group’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-77	Closed	–	–	1417
2022 Q3	$0	Hold	77	–	–	﹤0.01%	1424
2022 Q2	$0	Hold	77	–	–	﹤0.01%	1458
2022 Q1	$0	Hold	77	–	–	﹤0.01%	1437
2021 Q4	$0	Hold	77	–	–	﹤0.01%	1471
2021 Q3	$1K	Hold	77	–	–	﹤0.01%	1296
2021 Q2	$1K	Hold	77	–	–	﹤0.01%	1238
2021 Q1	$1K	Hold	77	–	–	﹤0.01%	1249
2020 Q4	$1K	Buy	+77	New	+$669	﹤0.01%	1231
2019 Q4	–	Sell	-181	Closed	–	–	1257
2019 Q3	$0	Hold	181	–	–	﹤0.01%	1208
2019 Q2	$1K	Hold	181	–	–	﹤0.01%	1192
2019 Q1	$1K	Buy	+181	New	+$891	﹤0.01%	1172

Other funds holding SURF

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Daiwa Securities Group's SURF Position: Q4 2022 in Review

Daiwa Securities Group sold out of Surface Oncology, Inc. Common Stock (SURF) in Q4 2022, closing a stake of 77 shares.

Daiwa Securities Group first reported a position in SURF in Q1 2019 and held it in 11 quarters. The position peaked at $1K in Q3 2021. 79 funds tracked by Wall St. Rank hold SURF as of Q4 2022.

Daiwa Securities Group reported no remaining Surface Oncology, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Daiwa Securities Group sold 77 Surface Oncology, Inc. Common Stock shares in Q4 2022.
Daiwa Securities Group first reported a position in Surface Oncology, Inc. Common Stock in Q1 2019 and held it in 11 quarters.
Daiwa Securities Group's Surface Oncology, Inc. Common Stock position peaked at $1K in Q3 2021.
79 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q4 2022.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.